TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Carls-Bergh Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
21,629
|
21,131
|
24,507 |
Financial expenses |
25
|
45
|
16 |
Earnings before taxes |
-1,044
|
150
|
4,000 |
EBITDA |
-737
|
563
|
4,331 |
Total assets |
26,441
|
23,623
|
22,095 |
Current assets |
14,932
|
12,684
|
11,007 |
Current liabilities |
6,753
|
4,070
|
3,193 |
Equity capital |
16,491
|
15,338
|
15,713 |
- share capital |
203
|
189
|
195 |
Employees (average) |
12
|
14
![]() |
14 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
62.4%
|
64.9%
|
71.1% |
Turnover per employee |
1,802
|
1,509
|
1,750 |
Profit as a percentage of turnover |
-4.8%
|
0.7%
|
16.3% |
Return on assets (ROA) |
-3.9%
|
0.8%
|
18.2% |
Current ratio |
221.1%
|
311.6%
|
344.7% |
Return on equity (ROE) |
-6.3%
|
1.0%
|
25.5% |
Change turnover |
-1,001
|
-2,640
|
3,062 |
Change turnover % |
-4%
|
-11%
|
14% |
Chg. No. of employees |
-2
|
0
![]() |
0 |
Chg. No. of employees % |
-14%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.